| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY | 2021-03-31 FY |
|---|---|---|---|---|---|---|
| Revenue | $82.03M | $152.31M | $166.80M | $206.00M | $12.36M | $2.13M |
| Cost of Revenue | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – |
| Operating Expenses | $158.29M | $247.98M | $245.00M | $193.82M | $215.21M | – |
| R&D | $112.21M | $195.16M | $192.13M | $147.75M | $173.76M | $50.05M |
| SG&A | $46.08M | $52.82M | $52.87M | $46.07M | $41.45M | $9.74M |
| Operating Income | -$76.26M | -$95.67M | -$78.20M | $12.18M | -$202.85M | -$57.67M |
| Interest Expense | – | – | – | – | – | – |
| Tax Expense | – | -$4.00K | $1.83M | $1.29M | – | – |
| Net Income | -$65.78M | -$80.94M | -$29.73M | $9.35M | -$203.67M | -$56.35M |
| EPS (basic) | -2.4000 | -3.0000 | -1.1200 | 0.3500 | -7.7400 | – |
| EPS (diluted) | -2.4000 | -3.0000 | -1.1200 | 0.3500 | -7.7400 | – |
| Shares (diluted) | $27.39M | $27.00M | $26.63M | $27.09M | $26.32M | – |